Bioceltix SA (BCX) Ratios

0 Followers

Bioceltix SA Ratios

PL:BCX's free cash flow for Q4 2025 was zł0.00. For the 2025 fiscal year, PL:BCX's free cash flow was decreased by zł and operating cash flow was zł0.00. See a summary of the company’s cash flow.

Ratios	TTM	Mar 26	Mar 25	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	―	32.51	12.34	5.24	1.94
Quick Ratio	―	32.51	12.33	5.24	1.94
Cash Ratio	―	31.19	10.52	4.35	1.83
Solvency Ratio	―	-6.15	-4.17	-5.84	-3.39
Operating Cash Flow Ratio	―	-5.52	-5.55	-6.89	-3.52
Short-Term Operating Cash Flow Coverage	―	-53.23	-26.30	-149.38	-68.28
Net Current Asset Value	zł ―	zł 68.94M	zł 35.98M	zł 8.94M	zł 1.86M
Leverage Ratios
Debt-to-Assets Ratio	―	<0.01	0.02	0.01	0.05
Debt-to-Equity Ratio	―	<0.01	0.02	0.02	0.06
Debt-to-Capital Ratio	―	<0.01	0.02	0.02	0.05
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	0.00	0.00
Financial Leverage Ratio	―	1.03	1.09	1.22	1.16
Debt Service Coverage Ratio	―	-38.10	-15.15	-99.86	-57.33
Interest Coverage Ratio	―	-82.90	-74.08	-470.16	-307.02
Debt to Market Cap	―	<0.01	<0.01	<0.01	<0.01
Interest Debt Per Share	―	0.10	0.24	0.05	0.10
Net Debt to EBITDA	―	4.09	2.34	0.69	0.45
Profitability Margins
Gross Profit Margin	―	0.00%	0.00%	0.00%	0.00%
EBIT Margin	―	0.00%	0.00%	0.00%	0.00%
EBITDA Margin	―	0.00%	0.00%	0.00%	0.00%
Operating Profit Margin	―	0.00%	0.00%	0.00%	0.00%
Pretax Profit Margin	―	0.00%	0.00%	0.00%	0.00%
Net Profit Margin	―	0.00%	0.00%	0.00%	0.00%
Continuous Operations Profit Margin	―	0.00%	0.00%	0.00%	0.00%
Net Income Per EBT	―	99.90%	100.21%	99.96%	99.49%
EBT Per EBIT	―	87.63%	78.96%	86.56%	92.71%
Return on Assets (ROA)	―	-20.04%	-35.59%	-107.48%	-149.00%
Return on Equity (ROE)	―	-20.69%	-38.78%	-130.77%	-173.20%
Return on Capital Employed (ROCE)	―	-23.58%	-48.71%	-149.30%	-258.66%
Return on Invested Capital (ROIC)	―	-23.48%	-47.07%	-146.51%	-242.32%
Return on Tangible Assets	―	-20.04%	-35.59%	-107.48%	-149.00%
Earnings Yield	―	-3.91%	-3.75%	-3.88%	-6.89%
Efficiency Ratios
Receivables Turnover	―	0.00	0.00	0.00	0.00
Payables Turnover	―	1.06	0.38	0.86	0.46
Inventory Turnover	―	0.00	41.03	120.47	0.00
Fixed Asset Turnover	―	0.00	0.00	0.00	0.00
Asset Turnover	―	0.00	0.00	0.00	0.00
Working Capital Turnover Ratio	―	0.00	0.00	0.00	0.00
Cash Conversion Cycle	―	-343.84	-939.59	-421.24	-786.01
Days of Sales Outstanding	―	0.00	0.00	0.00	0.00
Days of Inventory Outstanding	―	0.00	8.90	3.03	0.00
Days of Payables Outstanding	―	343.84	948.48	424.27	786.01
Operating Cycle	―	0.00	8.90	3.03	0.00
Cash Flow Ratios
Operating Cash Flow Per Share	―	-2.42	-3.91	-3.76	-2.37
Free Cash Flow Per Share	―	-2.81	-3.96	-3.88	-2.48
CapEx Per Share	―	0.39	0.05	0.12	0.11
Free Cash Flow to Operating Cash Flow	―	1.16	1.01	1.03	1.04
Dividend Paid and CapEx Coverage Ratio	―	-6.14	-73.05	-32.18	-22.48
Capital Expenditure Coverage Ratio	―	-6.14	-73.05	-32.18	-22.48
Operating Cash Flow Coverage Ratio	―	-38.43	-21.53	-84.25	-26.90
Operating Cash Flow to Sales Ratio	―	0.00	0.00	0.00	0.00
Free Cash Flow Yield	―	-3.63%	-4.52%	-4.31%	-6.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-25.59	-26.68	-25.77	-14.51
Price-to-Sales (P/S) Ratio	―	0.00	0.00	0.00	0.00
Price-to-Book (P/B) Ratio	―	5.29	10.34	33.70	25.13
Price-to-Free Cash Flow (P/FCF) Ratio	―	-27.57	-22.10	-23.20	-15.67
Price-to-Operating Cash Flow Ratio	―	-32.06	-22.41	-23.92	-16.37
Price-to-Earnings Growth (PEG) Ratio	―	3.36	4.43	-0.84	-0.16
Price-to-Fair Value	―	5.29	10.34	33.70	25.13
Enterprise Value Multiple	―	-19.22	-25.97	-25.98	-14.79
Enterprise Value	―	319.82M	364.61M	343.57M	125.61M
EV to EBITDA	―	-19.22	-25.97	-25.98	-14.79
EV to Sales	―	0.00	0.00	0.00	0.00
EV to Free Cash Flow	―	-22.73	-20.28	-22.59	-15.21
EV to Operating Cash Flow	―	-26.43	-20.56	-23.30	-15.89
Tangible Book Value Per Share	―	14.66	8.47	2.67	1.04
Shareholders’ Equity Per Share	―	14.66	8.47	2.67	1.54
Tax and Other Ratios
Effective Tax Rate	―	<0.01	>-0.01	<0.01	<0.01
Revenue Per Share	―	0.00	0.00	0.00	0.00
Net Income Per Share	―	-3.03	-3.28	-3.49	-2.67
Tax Burden	―	1.00	1.00	1.00	0.99
Interest Burden	―	0.88	1.02	1.00	1.00
Research & Development to Revenue	―	0.00	0.00	0.00	0.00
SG&A to Revenue	―	0.00	0.00	0.00	0.00
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	0.80	1.19	1.08	0.89

Currency in PLN